Business
The vaccination race: Doses are being administered, but which country is out in front?

The vaccination race: Doses are being administered, but which country is out in front?

Last year we spent a lot of time tracking COVID-19 cases and deaths, so it's nice to start following something a little cheerier — the number of vaccination doses administered.

Israel leads the world

The latest data from Bloomberg reveals that the US has administered the most vaccine doses of any country, with more than 5 million jabs already... jabbed. However, when you adjust for population it's actually Israel which is, quite considerably, ahead of the pace.

Israel's vaccination drive began urgently on December 20th and has now successfully administered the first dose of the Pfizer-BioNTech vaccine to more than 15% of its population in just 17 days. If Israel maintains that blistering pace (and they've actually been getting faster according to Our World In Data) they may be able to vaccinate the majority of their 9.1m adult population by the end of March.

It just so happens that Israel has an election coming up (also in March). For Prime Minister Benjamin Netanyahu presumably his election odds are likely to be closely entwined with his country maintaining the vaccination pace already set.

Pump those numbers up

In the US president-elect Joe Biden has outlined his ambitious goal for 100 million doses in his first 100 days in office. To hit that target, the US needs to administer almost 6 million doses a week, every week, until the end of April — meaning that the US needs to at least triple its current pace.

In the UK, which has just entered a third national lockdown, the story is similar. In London on Monday night PM Boris Johnson outlined a goal of roughly 14 million vaccinations by mid-February, a number which would cover the majority of people most at risk from COVID. To hit that target the UK would need to accelerate from its current pace of ~300,000 a week to roughly 2 million.

More Business

See all Business
The Sphere In Las Vegas

Washington D.C. looks set to get America’s second Sphere

Revenue for the Las Vegas version of the big orb has soared, but the sphere is still a money pit.

business

Ford reportedly in talks to buy hybrid vehicle batteries from Chinese auto giant BYD

Detroit’s Ford and China’s BYD are said to be in ongoing talks to partner on an agreement that would see Ford buy hybrid vehicle batteries from BYD, according to reporting from The Wall Street Journal.

The report comes just days after President Trump toured a Ford factory in Michigan and implied openness to Chinese automakers coming to the US.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

Still life of Ozempic and Wegovy with weight scale.

Lawsuit alleges Lilly, Novo locked up telehealth to kill compounded GLP-1s

Novo Nordisk CEO Mike Doustdar estimated that around 1.5 million US patients are using compounded versions of the company’s drugs.

Handshake

Big Pharma enters 2026 with an appetite for deals

At the JPMorgan Healthcare Conference, biotechs and Big Pharma signaled they’re primed for M&A this year, after a big year for deals in 2025.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.